Lishan Aklog, M.D.

Lishan Aklog, M.D.

Chairman of the Board and Chief Executive OfficeratLucid Diagnostics· In proxies 2022–2025

Pay in FY2025+26% from the year before · Lucid Diagnostics stock +33.1% the same year

Lishan Aklog, M.D. was paid $897.0K in FY2025 (Dec), up 26%. Lucid Diagnostics stock rose 33.1% that year.

Pay$100 in the stock at the end of FY21 → $20
Pay is from the Summary Compensation Table of each Lucid Diagnostics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lucid DiagnosticsPublic company · 4 yr
    • Chairman of the Board and Chief Executive Officer2022 – Present · 4 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?